Han Yan

Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia

L. Xia, W. Shi, H. Yan, 2022, Frontiers in Immunology.

Influence of graft composition in patients with hematological malignancies undergoing ATG-based haploidentical stem cell transplantation

Huafang Wang, L. Xia, Z. Zhong, 2022, Frontiers in Immunology.

How to improve the outcomes of elderly acute myeloid leukemia patients through allogeneic hematopoietic stem cell transplantation

L. Xia, Xuan Lu, Haoran Chen, 2023, Frontiers in Immunology.

Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation

Huafang Wang, W. Shi, L. Xia, 2022, Bone Marrow Transplantation.